Agathe Figarol

Vascularized tissue-on-chip

New in vitro models are crucial as animal alternatives for toxicology or drug transport assays. I thus develop healthy or pathological vascularized tissues within

physiological microsystems. 

Nanomedicine

I wish to overcome the current challenges in nanomaterial use for human health, notably focusing on the ability of nanocarriers to cross biological barriers.

Nanotoxicology

My goal is to support the shift from observational to predictive toxicology by understanding the impact of nanomaterial physico-chemical properties on their biological outcomes.